Navigation Links
Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
Date:11/6/2008

entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Orexigen Therapeutics, Inc.

(a development stage company)

Balance Sheets

(In thousands, except share and par value amounts)

September 30, December 31,

2008 2007

(Unaudited)

Assets

Current assets:

Cash and cash equivalents $52,533 $28,967

Investment securities,

available-for-sale 47,561 56,487

Prepaid expenses and other current assets 1,244 2,471

Total current assets 101,338 87,925

Property and equipment, net 2,138 924

Restricted cash 1,125 1,125

Other assets 831 1,346

Total assets $105,432 $91,320

Liabilities and stockholders' equity

Current liabilities:

Accounts payable and accrued expenses $16,919 $8,454

Deferred revenue, current portion 88 88

Long-term debt, current portion 6,404 4,735

Total current liabilities 23,411 13,277

Deferred revenue, less current portion 1,080 1,147

Long-term debt, less current portion 6,095 11,072

Other long-term liabilities 1,430 941

Commitments and contingencies

S
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
2. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
3. Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences
4. Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008
5. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
6. CV Therapeutics Reports 2008 Third Quarter Financial Results
7. Cell Therapeutics, Inc. (CTI) to Report 2008 Third Quarter Financial Results on November 7
8. According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
9. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
10. Nile Therapeutics to Present at Two Upcoming Investor Conferences
11. Arno Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...many, November 19 MONITORING FORCE...6th, 2009 Flibanserin in the,indication treatment-...s,disease for orphan drug status designation with ...uced dyskinesia is a complication of the mainstay,...rden to some of those,affected, since it may be di...
(Date:11/19/2009)...d,s Top Gene Synthesis Companies Form Internationa...est Practices in Risk Reduction ,Five Member Com...hesis Capacity , (PRWEB) ...ding gene synthesis companies today announced agre...ocol to promote biosecurity in the gene synthesis ...
(Date:11/18/2009)...18 Marrone Bio Innovations (MBI), ...ialization of effective and environmentally respon...has been named an IC20 company by the Investors, C...nal angel investing group. ,, Companies named t...ng results for all stakeholders, including investo...
(Date:11/18/2009)... polka-dotted postage stamp that can sniff out poi...olors. , As reported in the Sept. 13 issue of th...his team at the University of Illinois have develo...f toxic industrial chemicals (TICs) that is simple...dors. This sensor array could be useful in detect...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4Marrone Bio Innovations Named an IC20 Company 2Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
...usiness venture of Mike Strand in Eau Claire and a...an competition, has landed $250,000 from the Chip...ion, formerly Online Kiosks, has a plan to put vid...ople wait for appointments. After reaching the sta...e emerging growth category at Eau Claire Area Econ...
... Area Technical College,s Network Security Specia... viruses, worms and other threats to computer syst...the National Security Agency,s Committee on Natio... the state and 124 nationwide to carry the high-le...m precisely to what the NSA wishes students to be ...
...mbleGen Systems Inc. closed its latest, $8.2 mil...e venture funding to $50 million, the company said... Its microarrays, basically slides that can have t...anged in a grid, allow scientists and companies to..., , Cargill Ventures of Minneapolis, Minnesota, a...
Other Biology Technology:
(Date:11/23/2009)...hon Institute for Child Health Research has found ...sumption in pregnancy affects child behaviour in d...ed online in the international journal Addiction ...s was drawn from a random sample of more than 2000...s after the baby,s delivery, and were then followe...
(Date:11/23/2009)...erman . , Not just birds, but also a few spe...rchers at Princeton University in the U.S. and at ...zell, Germany studied the migratory behaviour of t...espertilionidae" with the help of mathematical mod... as well as long distances of various kinds of bat...
(Date:11/22/2009)...on can increase the likelihood of immune complicat...ernational team of researchers reports in the Nove... When the gene, called UGT2B17, is missing from th...ransplants have a significantly greater risk of a ...ease, in which immune cells from the donor attack ...
Breaking Biology News(10 mins):New study links alcohol in pregnancy to child behavior problems 2We're off then: The evolution of bat migration 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4Call for Proposals for Partners Investing in Nursings Future 57855 1Call for Proposals for Partners Investing in Nursings Future 57855 2Many Teens Circumvent Tanning Bed Laws 57851 1Many Teens Circumvent Tanning Bed Laws 57851 2Many Teens Circumvent Tanning Bed Laws 57851 3Secretary Shinseki Announces Progress on 241 4 Billion in Recovery Act Spending 57847 1Secretary Shinseki Announces Progress on 241 4 Billion in Recovery Act Spending 57847 2
... 1909, while harvesting a typical corn crop (Zea m...o unusual that it was initially believed to be a n...aside as a curiosity" and the specimen was designa...ny branches"). Due to the alteration of a single g...sel of the plant were more highly branched than us...
...x days is all it takes for a common, non-disease-c...d squamous cell cancer cells in laboratory culture...earchers. , "Our results suggest that adeno-assoc...ity of the population but has no known ill effects...effect on healthy cells," said Craig Meyers, Ph.D....
...ditor : The open access Public Library of Science ...os where you can see cells moving, be sure to chec...se, added by me. , Biologists have a new tool to...ing tissue. , Called two-photon laser-scanning mi...ic difference between the random wanderings of imm...
Other Biology News:$6.5 Million Grant for Microarray Center at Yale School of Medicine 2Study: Harmless virus kills some cancers 2Study: Harmless virus kills some cancers 3New tool reveals secrets of migrating cells 2New tool reveals secrets of migrating cells 3New tool reveals secrets of migrating cells 4New tool reveals secrets of migrating cells 5
Goat Anti-Human PARAINFLUENZA VIRUS 2+3 Polyclonal Antibody, Unconjugated from AbD Serotec
Goat Anti-PAPAIN Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Human JTV1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
APO-BrdU TUNEL Assay Kit with Alexa Fluor 488 anti-BrdU from Molecular Probes (Invitrogen)
Biology Products: